Alzheimer Afflicted Friends?
Posted: Sun Nov 17, 2019 5:53 pm
A clinical trial ended last December showing promise by exposing Alzheimer afflicted patients to an RF environment in the 900 MHz range.
The cap directs the Rf energy into the patient's head, breaking down the small protein aggregates (amyloid oligomers) in brain cells that are thought to initiate Alzheimer's development.
Company: NeuroEM Therapeutics
Cap: MemorEM cap
Treatment: Transcranial Electromagnetic Treatment
Ref: Journal of Alzheimer's Disease, Aug, 2019
Ref: QST, Oct 2019, page 83
The cap directs the Rf energy into the patient's head, breaking down the small protein aggregates (amyloid oligomers) in brain cells that are thought to initiate Alzheimer's development.
Company: NeuroEM Therapeutics
Cap: MemorEM cap
Treatment: Transcranial Electromagnetic Treatment
Ref: Journal of Alzheimer's Disease, Aug, 2019
Ref: QST, Oct 2019, page 83